RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes
2023-01-01 Mogavero, Andrea; Bironzo, Paolo; Righi, Luisella; Merlini, Alessandra; Benso, Federica; Novello, Silvia; Passiglia, Francesco
EGFR inhibition in NSCLC: New findings…. and opened questions?
2017-01-01 PASSIGLIA, Francesco; LISTI', Angela; CASTIGLIA, Marta; Perez, Alessandro; RIZZO, Sergio; BAZAN, Viviana; RUSSO, Antonio
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor
2015-01-01 Rolfo, Christian; Ruiz, Rossana; Giovannetti, Elisa; Gil-Bazo, Ignacio; Russo, Antonio; Passiglia, Francesco; Giallombardo, Marco; Peeters, Marc; Raez, Luis
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review
2023-01-01 Garbo, Edoardo; Del Rio, Benedetta; Ferrari, Giorgia; Cani, Massimiliano; Napoli, Valerio Maria; Bertaglia, Valentina; Capelletto, Enrica; Rolfo, Christian; Novello, Silvia; Passiglia, Francesco
Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression
2018-01-01 Pucci M; Reclusa Asiáin P; Duréndez Sáez E; Jantus-Lewintre E; Malarani M; Khan S; Fontana S; Naing A; Passiglia F; Raez LE; Rolfo C; Taverna S.
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…
2017-01-01 Thungappa S; Ferri J; Caglevic C; Passiglia F; Raez L; Rolfo C
Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
2020-01-01 Remon J.; Passiglia F.; Ahn M.-J.; Barlesi F.; Forde P.M.; Garon E.B.; Gettinger S.; Goldberg S.B.; Herbst R.S.; Horn L.; Kubota K.; Lu S.; Mezquita L.; Paz-Ares L.; Popat S.; Schalper K.A.; Skoulidis F.; Reck M.; Adjei A.A.; Scagliotti G.V.
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era
2021-01-01 Passiglia F.; Leone G.; Olmetto E.; Delcuratolo M.D.; Tabbo F.; Reale M.L.; Bertaglia V.; Consito L.; Bironzo P.; Capelletto E.; Novello S.
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection
2018-01-01 Banna, Giuseppe Luigi; Passiglia, Francesco; Colonese, Francesca; Canova, Stefania; Menis, Jessica; Addeo, Alfredo; Russo, Antonio; Cortinovis, Diego Luigi
Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?
2018-01-01 Passiglia, Francesco; Novello, Silvia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes | 2023 | Mogavero, Andrea; Bironzo, Paolo; Righi, Luisella; Merlini, Alessandra; Benso, Federica; Novello, Silvia; Passiglia, Francesco | |
| EGFR inhibition in NSCLC: New findings…. and opened questions? | 2017 | PASSIGLIA, Francesco; LISTI', Angela; CASTIGLIA, Marta; Perez, Alessandro; RIZZO, Sergio; BAZAN, Viviana; RUSSO, Antonio | |
| Entrectinib: A potent new TRK, ROS1, and ALK inhibitor | 2015 | Rolfo, Christian; Ruiz, Rossana; Giovannetti, Elisa; Gil-Bazo, Ignacio; Russo, Antonio; Passiglia, Francesco; Giallombardo, Marco; Peeters, Marc; Raez, Luis | |
| Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review | 2023 | Garbo, Edoardo; Del Rio, Benedetta; Ferrari, Giorgia; Cani, Massimiliano; Napoli, Valerio Maria; Bertaglia, Valentina; Capelletto, Enrica; Rolfo, Christian; Novello, Silvia; Passiglia, Francesco | |
| Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression | 2018 | Pucci M; Reclusa Asiáin P; Duréndez Sáez E; Jantus-Lewintre E; Malarani M; Khan S; Fontana S; Naing A; Passiglia F; Raez LE; Rolfo C; Taverna S. | |
| Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… | 2017 | Thungappa S; Ferri J; Caglevic C; Passiglia F; Raez L; Rolfo C | |
| Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations | 2020 | Remon J.; Passiglia F.; Ahn M.-J.; Barlesi F.; Forde P.M.; Garon E.B.; Gettinger S.; Goldberg S.B.; Herbst R.S.; Horn L.; Kubota K.; Lu S.; Mezquita L.; Paz-Ares L.; Popat S.; Schalper K.A.; Skoulidis F.; Reck M.; Adjei A.A.; Scagliotti G.V. | |
| Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era | 2021 | Passiglia F.; Leone G.; Olmetto E.; Delcuratolo M.D.; Tabbo F.; Reale M.L.; Bertaglia V.; Consito L.; Bironzo P.; Capelletto E.; Novello S. | |
| Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection | 2018 | Banna, Giuseppe Luigi; Passiglia, Francesco; Colonese, Francesca; Canova, Stefania; Menis, Jessica; Addeo, Alfredo; Russo, Antonio; Cortinovis, Diego Luigi | |
| Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle? | 2018 | Passiglia, Francesco; Novello, Silvia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 58
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 58
Data di pubblicazione
- 2023 6
- 2022 7
- 2021 5
- 2020 4
- 2018 7
- 2017 6
- 2016 6
- 2015 7
- 2014 9
- 2013 1
Rivista
- CRITICAL REVIEWS IN ONCOLOGY HEMA... 6
- CANCER TREATMENT REVIEWS 5
- EXPERT OPINION ON BIOLOGICAL THERAPY 3
- JOURNAL OF THORACIC ONCOLOGY 3
- TRANSLATIONAL LUNG CANCER RESEARCH 3
- EXPERT OPINION ON INVESTIGATIONAL... 2
- EXPERT REVIEW OF ANTICANCER THERAPY 2
- ONCOTARGET 2
- TRANSLATIONAL CANCER RESEARCH 2
- ANALYTICAL CELLULAR PATHOLOGY 1
Keyword
- Humans 12
- NSCLC 10
- Oncology 9
- Lung Neoplasms 7
- Pharmacology 7
- EGFR 5
- Immunotherapy 5
- Non-small cell lung cancer 5
- Pharmacology (medical) 5
- Resistance 5
Lingua
- eng 58
Accesso al fulltext
- reserved 35
- open 19
- no fulltext 4